Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

NCT01224665

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 35 locations
View Trial Details
Completed

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging

NCT02462239

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • London Regional Cancer Centre London, Ontario, Canada
  • Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada
  • Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada
View Trial Details
Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

NCT02216214

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site US00066 Huntsville, Alabama, United States
  • Site US00148 Mobile, Alabama, United States
  • Site US00009 Anchorage, Alaska, United States
  • Site US00020 Tucson, Arizona, United States
View all 120 locations
View Trial Details
Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00912964

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Chandler, Arizona, United States
View all 151 locations
View Trial Details
Completed

Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

NCT05584657

Conditions
Cystitis, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations
  • Medical Facility Cullman, Alabama, United States
  • Medical Facility Saraland, Alabama, United States
  • Medical Facility Sheffield, Alabama, United States
  • Medical Facility Peoria, Arizona, United States
View all 167 locations
View Trial Details

Related conditions